Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres
about
Updated systematic review and meta-analysis of the performance of risk prediction rules in children and young people with febrile neutropeniaPredicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis.Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer.Outpatient management of febrile neutropenia in children with cancerThe influence of different fever definitions on the rate of fever in neutropenia diagnosed in children with cancerPredicting infectious complications in neutropenic children and young people with cancer (IPD protocol).Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia.Variation in Management of Fever and Neutropenia Among Pediatric Patients With Cancer: A Survey of Providers in Michigan.Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people.Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children--a systematic review of prospective trials.Developing a national 'low risk' febrile neutropenia framework for use in children and young people's cancer care.Early Discharge of Neutropenic Pediatric Oncology Patients Admitted With Fever.Infections in hospitalized children and young adults with acute leukemia in Morocco.Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia.Risk-stratification management of febrile neutropenia in pediatric hematology-oncology patients: Results of a French nationwide survey.Management of chemotherapy-induced febrile neutropenia in pediatric oncology patients: A North American survey of pediatric hematology/oncology and pediatric infectious disease physicians.Core outcomes and definitions for pediatric fever and neutropenia research: a consensus statement from an international panel.Febrile neutropenia: median door-to-needle time - results of an initial audit.Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein.Different fever definitions and the rate of fever and neutropenia diagnosed in children with cancer: a retrospective two-center cohort study.First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study.Febrile neutropenia in children with cancer: a retrospective Norwegian multicentre study of clinical and microbiological outcome.Could CD64 expression be used as a predictor of positive culture results in children with febrile neutropenia?Bloodstream infection in paediatric cancer centres--leukaemia and relapsed malignancies are independent risk factors.Variation in practice remains in the UK management of paediatric febrile neutropenia.The influence of different fever definitions on diagnostics and treatment after diagnosis of fever in chemotherapy-induced neutropenia in children with cancer.
P2860
Q28729011-0824B61C-B538-4E11-962B-7D5FCC933BC1Q30730077-1CCF4166-10EC-4BC8-A9A0-B7714C3109EEQ34132502-9FF48474-5219-47DA-ACC4-F19590A214C6Q35010364-2FB1994C-B586-441E-A8F6-5D0C11C49684Q35074650-7440F7F8-FC77-4DDA-B58D-8F800E521814Q35958125-0B763D82-45DD-4E30-B1BD-E03201478A23Q36241163-96A2BA4A-0C1D-42B6-BBA5-9CA702EBCE3CQ36727621-C7F2B8C9-15D9-4044-A4E6-C55238A516ACQ37771732-F7FD97CB-3C0D-4C22-8DC3-7D5631BA5070Q37991965-AE313DAA-A360-4505-BC8D-2077E3828C25Q38069428-5451DC85-DC22-4D6A-8343-F07C21B8904FQ38838351-6E8BD8D7-0BCE-479D-BC11-714DA1C0D99FQ38970572-F28AF5C0-FA72-4E99-B864-B7ABCF70C5C2Q39785801-A0A2B379-5E83-4FC3-B4DB-268F012A256CQ40084542-D5399B89-CEF8-4557-AE1E-3F35B228D77DQ40117707-CE53CE9D-DEDF-4049-A17B-9EFE45C73FB8Q40180396-CBA1078C-3CB0-45EE-830F-3B0FC01CC3BCQ40210717-CD11D6A4-4298-4D60-93F5-93BFA63D84B0Q40233807-38661E6E-18FF-44B4-8A05-49B4952C29C1Q40266414-398EA61A-2627-4A22-B741-782F0F9E00DBQ40298464-D65078C4-C853-471C-9C5B-1F11D9D0C463Q40437471-28B30309-0837-4DD2-849E-9058668ED27EQ40870172-0A31E869-4776-457C-8063-1C74999CB217Q41170281-D168C124-41DA-4109-B778-0B11173952E9Q52817953-058FCF26-354A-418A-BA38-FF7F61F9D423Q54270181-B97FB722-E053-41BD-AC2D-36325D143E92
P2860
Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Variation in policies for the ...... n's Cancer Study Group centres
@ast
Variation in policies for the ...... n's Cancer Study Group centres
@en
type
label
Variation in policies for the ...... n's Cancer Study Group centres
@ast
Variation in policies for the ...... n's Cancer Study Group centres
@en
prefLabel
Variation in policies for the ...... n's Cancer Study Group centres
@ast
Variation in policies for the ...... n's Cancer Study Group centres
@en
P2093
P2860
P356
P1476
Variation in policies for the ...... n's Cancer Study Group centres
@en
P2093
Bob Phillips
Julia C Chisholm
Karen Selwood
Roderick Skinner
Sheila M Lane
United Kingdom Children's Cancer Study Group
P2860
P304
P356
10.1136/ADC.2006.102699
P407
P50
P577
2007-02-06T00:00:00Z